Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Monday, September 29

5:30 PM - 5:40 PM PT

266 - Stereotactic Body Radiation Therapy (SBRT) for Renal Tumors: A Prospective Phase II Study
Speaker: Wang, Katelyn - Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON
5:30 PM - 5:40 PM PT

271 - Outcomes of SABR or Surgery for Early-Stage Lung Cancer in Patients with Interstitial Lung Disease (ILD)
Speaker: Tomassen, Mathijs, MD - Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam
5:30 PM - 5:40 PM PT

276 - Design and Implementation of Combined Spatially Fractionated Radiotherapy and Image-Guided On-Treatment Biopsy for Resectable Soft Tissue Sarcoma Patients Enrolled in Prospective Clinical Trial LCCC22
Speaker: Rankine, Leith, PhD - University of North Carolina, Chapel Hill, NC
5:40 PM - 5:50 PM PT

262 - Safety and potential radiosensitizing effect of Olaparib in combination with breast radiotherapy for TNBC patients with residual disease: long-term results from a phase I trial
Speaker: Loap, Pierre, MD - Institut Curie, Paris
5:40 PM - 5:50 PM PT

267 - Neoadjuvant Pembrolizumab and Stereotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma (NAPSTER): A Phase II Randomised Clinical Trial
Speaker: Ali, Muhammad, MBBS - Peter MacCallum Cancer Centre, Melbourne 8006, VIC
5:40 PM - 5:50 PM PT

272 - A Feasibility and Toxicity Analysis of Single Fraction Stereotactic Body Radiation Therapy for Post-Operative Non-Small Cell Lung Cancer
Speaker: Farrugia, Mark, MD, PhD - Roswell Park Cancer Institute, Buffalo, NY
5:40 PM - 5:50 PM PT

277 - Feasibility, Safety and Patient Reported Early Clinical Outcomes of Spatially Fractionated Radiotherapy of Unresectable Bulky Tumors Followed by SBRT Delivery
Speaker: Pokhrel, Damodar, PhD - UK Kentucky, Markey Comprehensive Cancer Center, Lexington, KY
5:50 PM - 6:00 PM PT

278 - Low Radiation Doses to Peripheral Tumor Tissue in Metabolism Guided Lattice Irradiation Based on LATTICE-01 Study: A Search for Dose Constraints to Determine a "Spatial Analysis of Peripherical Tissue
Speaker: Ferrantelli, Giacomo, MD - University of Messina, BIOMORF Department, Messina
5:50 PM - 6:00 PM PT

Discussant
Speaker: Tang, Chad, MD - MD Anderson Cancer Center, Houston, TX
5:50 PM - 6:00 PM PT

Discussant
Speaker: Chang, Joe, MD, PhD, MS, FASTRO - MD Anderson Cancer Center, Houston, TX

Tuesday, September 30

8:00 AM - 8:10 AM PT

279 - Utilization of a Lumpectomy Bed Boost after Whole Breast Radiotherapy Does Not Improve Ipsilateral Breast Tumor Recurrence Risk in Patients with Ductal Carcinoma In-Situ Treated on Three NSABP Trials
Speaker: Khan, Atif, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY
8:00 AM - 8:10 AM PT

289 - Sequential Chemo-immunotherapy as a Novel Bridging Strategy for Non-Complete Responders after Neoadjuvant Chemoradiotherapy in Esophageal Cancer: First Prospective Phase 2 Trial Challenging Immediate
Speaker: Wang, Qifeng, MD, PhD - Sichuan Cancer Hospital and Institute, Chengdu, Sichuan